Historical record - last NADAC publication: 10/21/2020

Product Information

ATORVASTATIN 80 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1184 per EA under NDC 69097091105. Its NADAC has been published 212 times since Oct 12, 2016.

The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ATORVASTATIN 80 MG TABLET

ATORVASTATIN CALCIUM
$0.1184per EA
High Outlier

Strength

80 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097091105

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

10/21/2020

Approval Type

Generic (ANDA)

FDA Application

ANDA205519

On Market Since

8/4/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 80 MG TABLET has been published 212 times since Oct 12, 2016, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1184 per EA
All-time high$0.1828 (Jan 11, 2017)
All-time low$0.1184 (Oct 21, 2020)
Median price$0.1405
Average price$0.1405
Largest weekly change+22.0% (Dec 21, 2016)
Weeks tracked212
Tracking sinceOct 12, 2016

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-17.9%

Generic Alternatives

The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 80 MG TABLET, manufactured by Cipla USA Inc., is $0.1184 per EA (NDC 69097091105), effective Oct 28, 2020.

How has the price of ATORVASTATIN 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 80 MG TABLET has declined 17.9%. It has been tracked across 212 weekly CMS publications since Oct 12, 2016.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 80 MG TABLET?

Since Oct 12, 2016, the NADAC for ATORVASTATIN 80 MG TABLET has ranged from a low of $0.1184 (Oct 21, 2020) to a high of $0.1828 (Jan 11, 2017), with a median of $0.1405 per EA.

Are there cheaper alternatives to ATORVASTATIN 80 MG TABLET?

Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ATORVASTATIN 80 MG TABLET, is $0.0635 per EA — about 46% below ATORVASTATIN 80 MG TABLET.

Who manufactures ATORVASTATIN 80 MG TABLET?

ATORVASTATIN 80 MG TABLET (NDC 69097091105) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.